HBC Hofseth BioCare ASA

0.1086USD1.050 NOK · OSL+3.96%Mkt Cap: 55.00M USDP/E: —

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The compa…

Key Statistics

Company
Market Cap55.00M USD
Enterprise Value82.34M USD
Revenue (TTM)28.01M USD
Gross Profit9.86M USD
Net Income (TTM)-13.95M USD
Revenue/Share0.06 USD
Last Price0.1086 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees78
CountryNO
SectorConsumer Defensive
IndustryPackaged Foods
ISINNO0010598683
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-10.89
EV/Revenue2.94
P/S1.96
P/B-350.00
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.10345% of range0.2079
52W High0.2079 USD
52W Low0.1034 USD
Profitability
Gross Margin37.21%
Oper. Margin-33.04%
EBITDA Margin-26.99%
Profit Margin-52.62%
ROE180.22%
ROA-34.21%
ROIC-50.76%
ROCE-73.34%
Growth
Revenue Growth52.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.88M USD
CapEx (TTM)2.12M USD
FCF Margin-44.53%
FCF Yield-22.67%
Net Debt25.69M USD
Net Debt/EBITDA-3.40
Net Debt/FCF—
Balance Sheet
Debt/Equity-4.81
Current Ratio0.96
Quick Ratio0.50
Book Value/Sh-0.0003 USD
Cash/Share0.0066 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.506.47M
Float77.68M
Insiders39.23%
Institutions12.97%
Technical
SMA 500.1315 (-17.4%)
SMA 2000.1372 (-20.8%)
Beta0.32
S&P 52W Chg12.00%
Avg Vol (30d)116.57K
Avg Vol (10d)101.65K
Technical Indicators
RSI (14)34.6
MACD-0.0665
MACD Signal-0.0593
MACD Hist.-0.0071
BB Upper0.1414 USD
BB Middle0.1200 USD
BB Lower0.0986 USD
BB Width35.74%
ATR (14)0.0097 USD
Vol Ratio (20d)0.93x

About Hofseth BioCare (OSL: HBC)

›

Hofseth BioCare (OSL: HBC) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 78 employees.

The shares were at 1.050 NOK on 19 November 2026, down 41.0% over 52 weeks. Its 52-week range is 1.000 NOK to 2.010 NOK: the price is 47.8% below the high and 5.0% above the low.

Its market capitalisation is 531.79M NOK.

Hofseth BioCare reports return on equity of 180.2%, an operating margin of -33.0% and revenue up 52.1% year over year.

Its debt exceeds its cash by 248.42M NOK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.